Real World Data of Clinical Trial Eligibility and Outcome Analysis in Patients With Metastatic NSCLC

被引:0
|
作者
Yellala, A. [1 ]
Tulpule, S. [2 ]
Oakley, C. [1 ]
High, R. [1 ]
Ganti, A. K. [1 ]
Marr, A. [1 ]
机构
[1] Univ Nebraksa, Med Ctr, Hematol Oncol, Omaha, NE USA
[2] St Louis Univ, Sch Med, St Louis, AL USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P10.01
引用
收藏
页码:S998 / S998
页数:1
相关论文
共 50 条
  • [1] Clinical Trial Eligibility and Outcomes in Patients With Metastatic NSCLC Treated Outside of Clinical Trials
    Oakley, Clayton K.
    Yellala, Amulya
    Tulpule, Sunil
    High, Robin
    Kishor, Apar
    Marr, Alissa S.
    ONCOLOGY-NEW YORK, 2024, 38 (12):
  • [2] Eligibility of real-world patients with metastatic lung cancer for clinical trial participation: A population-based analysis.
    Batra, Atul
    Kong, Shiying
    Rigo, Rodrigo
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (29)
  • [3] Eligibility of real-world patients with metastatic breast cancer for clinical trials
    Batra, Atul
    Kong, Shiying
    Cheung, Winson Y.
    BREAST, 2020, 54 : 171 - 178
  • [4] Eligibility of real-world patients with metastatic breast cancer in clinical trials
    Batra, A.
    Kong, S.
    Rigo, R.
    Cheung, W.
    ANNALS OF ONCOLOGY, 2020, 31 : S70 - S70
  • [5] Thyroid Disfunction in Advanced NSCLC Patients Treated with Nivolumab out of Clinical Trial: A Real-World Data Analysis
    Palmero, R.
    Ruffinelli, J. C.
    Alanya, E.
    Marin, J. A.
    Ferrer, M.
    Jove, M.
    Mesia, C.
    Arellano, M.
    Brao, I.
    Cardenal, F.
    Peiro, I.
    Nadal, E.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2432 - S2432
  • [6] Real World Data of Patients ≥ 80 Years Old With Metastatic NSCLC: Evaluation of an Underrepresented Population in Clinical Trials
    Visani, Filipe
    Montella, Tatiane
    Paes, Rafael Duarte
    Afonso, Nathalia Gimenes
    Negreiros, Izabella
    De Marchi, Pedro
    Ferreira, Carlos Gil
    Dienstmann, Rodrigo
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : S14 - S14
  • [7] MAPPING REAL-WORLD ANKYLOSINC SPONDYLITIS PATIENTS TO CLINICAL TRIAL ELIGIBILITY CRITERIA
    Sholter, Dalton
    Inman, Robert
    Masetto, Ariel
    Rahman, Proton
    Rampakakis, Emmanouil
    Asin-Milan, Odalis
    Rachich, Meagan
    Nantel, Francois
    Lehman, Allen J.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 26 - 27
  • [8] Mapping Real-World Ankylosing Spondylitis Patients to Clinical Trial Eligibility Criteria
    Sholter, Dalton
    Inman, Robert
    Masetto, Ariel
    Rahman, Proton
    Rampakakis, Emmanouil
    Asin-Milan, Odalis
    Rachich, Meagan
    Nantel, Francois
    Lehman, Allen
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1101 - 1101
  • [9] Mapping Real-World Psoriatic Arthritis Patients to Clinical Trial Eligibility Criteria
    Arendse, Regan
    Haaland, Derek
    Fortin, Isabelle
    Rahman, Proton
    Rampakakis, Emmanouil
    Asin-Milan, Odalis
    Rachich, Meagan
    Nantel, Francois
    Lehman, Allen
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1035 - 1036
  • [10] Mapping Real-World Rheumatoid Arthritis Patients to Clinical Trial Eligibility Criteria
    Keystone, Edward
    Olszynski, Wojciech
    Bessette, Louis
    Rahman, Proton
    Rampakakis, Emmanouil
    Lehman, Allen
    Asin-Milan, Odalis
    Nantel, Francois
    Rachich, Meagan
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1107 - 1108